AustinAndersonDO

Rheumatology • Silver Spring, MD

Medical Officer, Division of Rheumatology and Transplant Medicine, FDA

Join to view full profile

Dr. Anderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anderson's full profile

Already have an account?

Office
10903 New Hampshire Ave
Silver Spring, MD 20993

Summary

Dr. Anderson is a Rheumatologist and Medical Officer in the Division of Rheumatology and Transplant Medicine at the U.S. Food and Drug Administration (FDA). Prior to joining the FDA, he was an Assistant Professor of Medicine in the Division of Rheumatology and Clinical Immunology at the University of Florida.

Education & Training

University of FloridaFellowship, Rheumatology, 2017 - 2019
University of FloridaResidency, Internal Medicine, 2014 - 2017
University of FloridaInternship, Internal Medicine, 2014 - 2015
Philadelphia College of Osteopathic MedicineClass of 2014

Certifications & Licensure

MD State License 2019 - 2026
FL State License 2019 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
International Society of Clinical Densitometry Certified Clinical Densitometrist

Awards, Honors, & Recognition

FDA Honor Award Recepient U.S. Food and Drug Administration, 2023
Resident of the Month University of Florida Shands Hospital, 2017
Key Award University of Florida Shands Hospital, 2016

Publications & Presentations

PubMed

57 citations
Soluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor Immunity
Jianping Huang, Caroline Jochems, Austin M. Anderson, Tara Talaie, Alessandra Jales
Journal of Immunology. 2013-05-15
101 citations
Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role.
Jianping Huang, Caroline Jochems, Tara Talaie, Austin M. Anderson, Alessandra Jales
Blood. 2012-10-11
1 citations
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization.
Qi Liu, Raj Nair, Ruihao Huang, Hao Zhu, Austin Anderson
Clinical Pharmacology and Therapeutics. 2024-04-01

Books/Book Chapters

Sjogren's Syndrome and Oral Health
Chapter: B Cell Expansion and Neoplasia in Sjögren’s Syndrome
Page 117 - 136Austin Anderson, Erin Hudson, Lijun Yang, Winnie Hui, Shuhong Han, Haoyang Zhuang, Robert Thoburn, Westley ReevesEditors: Seunghee Cha.Springer, ChamEdition 1,2021

Press Mentions

FDA to Review New Rheumatology Approvals, Safety Messaging, ProgramsNovember 8th, 2024